» Articles » PMID: 38570594

Long-term Pulmonary Outcomes in BPD Throughout the Life-course

Overview
Journal J Perinatol
Date 2024 Apr 3
PMID 38570594
Authors
Affiliations
Soon will be listed here.
Abstract

Respiratory disease is one of the most common complications of preterm birth. Survivors of prematurity have increased risks of morbidities and mortalities independent of prematurity, and frequently require multiple medications, home respiratory support, and subspecialty care to maintain health. Although advances in neonatal and pulmonary care have improved overall survival, earlier gestational age, lower birth weight, chorioamnionitis and late onset sepsis continue to be major factors in the development of bronchopulmonary dysplasia. These early life events associated with prematurity can have respiratory consequences that persist into adulthood. Furthermore, after initial hospital discharge, air pollution, respiratory tract infections and socioeconomic status may modify lung growth trajectories and influence respiratory outcomes in later life. Given that the incidence of respiratory disease associated with prematurity remains stable or increased, there is a need for pediatric and adult providers to be familiar with the natural history, manifestations, and common complications of disease.

Citing Articles

Safety, Efficacy and Bio-Distribution Analysis of Exosomes Derived From Human Umbilical Cord Mesenchymal Stem Cells for Effective Treatment of Bronchopulmonary Dysplasia by Intranasal Administration in Mice Model.

Xu W, Jieda X, Wu Y, Du F, Ma L, Luo L Int J Nanomedicine. 2025; 20:2521-2553.

PMID: 40034220 PMC: 11874997. DOI: 10.2147/IJN.S501843.

References
1.
Ohuma E, Moller A, Bradley E, Chakwera S, Hussain-Alkhateeb L, Lewin A . National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis. Lancet. 2023; 402(10409):1261-1271. DOI: 10.1016/S0140-6736(23)00878-4. View

2.
Pryhuber G, Maitre N, Ballard R, Cifelli D, Davis S, Ellenberg J . Prematurity and respiratory outcomes program (PROP): study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the United States. BMC Pediatr. 2015; 15:37. PMC: 4407843. DOI: 10.1186/s12887-015-0346-3. View

3.
NORTHWAY Jr W, ROSAN R, Porter D . Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967; 276(7):357-68. DOI: 10.1056/NEJM196702162760701. View

4.
Sillers L, Alexiou S, Jensen E . Lifelong pulmonary sequelae of bronchopulmonary dysplasia. Curr Opin Pediatr. 2020; 32(2):252-260. DOI: 10.1097/MOP.0000000000000884. View

5.
Martinez F . Early-Life Origins of Chronic Obstructive Pulmonary Disease. N Engl J Med. 2016; 375(9):871-8. DOI: 10.1056/NEJMra1603287. View